How COVID-19 Impacted on Molecular Diagnostics ?

Impact of COVID-19 on Molecular Diagnostics in Healthcare Industry

The COVID-19 pandemic has affected the molecular diagnostics market positively on a global level. The persistence of COVID-19 for a longer period has increased the need for molecular diagnostic tools and instruments to diagnose certain diseases, especially the COVID-19 virus. During the COVID-19 pandemic, manufacturers expect a boost in their market as demand for instruments such as PCR or real-time PCR or COVID-19 test kits has increased with the spread of coronavirus. The increasing demand for molecular diagnostics instruments, tools, kits, software, and services will propel the growth of the global molecular diagnostics market. The COVID-19 has led to the lockdown worldwide, which has tremendously impacted the molecular diagnostics market.

Moreover, the coronavirus is life-threatening, and proper diagnosis on time has become important and molecular diagnostics are the solution for that. COVID-19 is a contagious disease and can be spread easily via droplet particles. The necessity for the diagnosis of positive cases has increased to ensure prompt care of the affected individual and to curb the further spread of coronavirus in the population. RT-PCR is an important molecular diagnostic instrument that is used to detect SARS-CoV-2. Hence, with the ongoing COVID-19 pandemic, the demand for molecular diagnostics has increased tremendously and will boost the growth of the market.

STRATEGIC INITIATIVES BY MANUFACTURERS

The rising demand for molecular diagnostics tools, services, instruments and others has led the manufacturers to launch new products in the market for different diseases even during COVID-19 time. Additionally, manufacturers partner with other companies to launch new technology or products or acquire them or merge with them. All these strategies opted by manufacturers is to gain more market share in the market.

· In March 2021, Hologic, Inc. acquired diagenode, a molecular diagnostic assay and epigenetics product manufacturer for USD 159 million.

· In April 2021, QIAGEN partnered with DiaSorin to launch LIAISON LymeDetect Assay for early diagnosis of Lyme Borreliois. It is based on QantiFERON technology.

· In June 2020, Myriad Genetics, Inc. launched AMPLIFY Technology to increase the performance of Prequel NIPS Kit, which is used in prenatal screening.

· In March 2021, F. Hoffmann-La Roche Ltd signed a merger agreement with GenMark Diagnostics, Inc. To access their novel technology to test for a broad range of pathogen from single patient sample.

RNA and DNA detection

The increasing number of launches, mergers, acquisitions, and partnerships by manufacturers to develop new molecular diagnostics products, services, or technologies to fulfill the rising demand for molecular diagnostics will boost the market's growth.

AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVES FOR GROWTH OF THE MARKET

COVID-19

For instance,

· In August 2020, According to Spandidos Publications, China National Medical Products Administration opened a special channel to approve new pharmaceuticals for urgent clinical needs and 18 nucleic acid detection kits, one sequencing-related equipment, 11 protein detection kits, and software have been approved until April 23, 2020.

· In March 2020, Cepheid received Emergency Use Authorization (EUA) from the U.S. Food & drug Administration (FDA) for their product-Xpert Xpress SARS-CoV-2, a molecular diagnostic test for detection of SARS-CoV virus.

The COVID-19 pandemic has increased the demand for molecular diagnostics to provide proper screening, diagnosis, and treatments for COVID-19.

IMPACT ON DEMAND

PCR and RT-PCR

For instance,

· In March 2021, Quidel Corporation expanded its manufacturing facility in California, U.S., to produce Quidel’s popular QuickVue line of products, which helps detect and diagnose COVID-19 infection.

· In May 2021, Beckman Coulter, Inc. launched a fully automated and quantitative COVID-19 IgG Test to assess the number of antibodies of COVID-19.

Access SARS-CoV-2 Antigen assay

· In April 2020, Bio-Rad Laboratories, Inc. launched a serology assay to detect COVID-19 antibodies.

· In June 2020, Cepheid announced the development of the next-generation test of the Four-in-One combination test for SARS-CoV-2, Flu A, Flu B, and RSV. The XpertSource: Company Website, Press Releases, DBMR Analysis Xpress SARS-CoV-2/Flu/RSV helps in the detection of 4 viruses from a single patient sample.

· In September 2020, QIAGEN launched QIAreach SARS-CoV-2 Antigen Test, which analysis the antigen in less than 15 minutes. This new product launch helps in detecting the COVID-19 virus at a much faster rate.

The rising number of launches for COVID-19 test kits and molecular diagnostics tools by manufacturers to offer rapid and accurate analysis of the COVID-19 virus will boost the global molecular diagnostics market growth. Moreover, the demand for molecular diagnostics will be increasing even after COVID-19 to cure and diagnose other diseases.

IMPACT ON PRICE

The molecular diagnostics instruments are costly as the reagents' needs for it or any other supplies are on the higher side, making the total service costlier. Also, the research and manufacturing of molecular diagnostics products are tedious and time-consuming, making the instrument expensive. Furthermore, instruments, laboratory supervision, utility, space, and supervision ads up to additional prices. The high cost of instrumentation and services for molecular diagnostics makes it hard to afford for lower-class families, restricting the market's growth. Moreover, during a pandemic, the demand for molecular diagnostics products, especially PCR machines, real-time PCR (qPCR) machines, and others, has increased and with rising demand, the prices for services and instruments has also increased.

IMPACT ON SUPPLY CHAIN

kits

THE RISING COVID-19 CASES ARE LEADING THE MOLECULAR DIAGNOSTICS MARKET.

The rising number of COVID-19 patients is increasing the need for molecular diagnostics instruments and services for proper diagnosis and treatment, which will boost market growth in the future. Also, molecular diagnostics are the primary diagnostic tools for rapid and accurate diagnosis and for the screening, isolation, treatment, prevention, and control of COVID‑19. The rise in prevalence of COVID-19 cases is the main factor boosting the growth of the market.

For instance,

· In July 2021, According to World meters, there are 30,619,932 cases of COVID-19 in India.

· In July 2021, According to World Health Organisation (WHO), there are 183,700,343 confirmed cases of COVID-19 patients worldwide.

· In January 2020, According to World Health Organisation (WHO), there are 33,378,240 confirmed cases in the U.S.

The rise in COVID-19 cases and its proper diagnosis increases the demand for molecular diagnostics.

CONCLUSION

COVID-19

Cards you may also be interested in
Significant Impact of COVID-19 on PPE Kits in Healthcare Industry
prakash7793
1
0
0
Order Xanax online for Anxiety and panic attacks
onlinehealthsus
1
0
0
How to purchase lab products?
ozahubseo5
1
0
0
How COVID-19 Impacted on Integrated Cardiology Devices in Healthcare ?
amitshinde7793
3
0
0
Is it worth using Prozac (fluoxetine) as an antidepressant? Find out More!
Texas1
1
0
0
Fungal Infections Market Foraying into Emerging Economies 2028
poojashuukla93
1
0
0
Best gynecologist in Pune for Cervical Disorders
Gynecologist
1
0
0
Injection Trays Market by Competitive Landscape, SWOT Analysis, Opportunities and Challenges, Growth by 2021-2028
poojashuukla93
1
0
0
Medulloblastoma Drug Market Production, Sales and Consumption Status and acurate Research Report and Forecast 2028
poojashuukla93
1
0
0
Cell Counting Market - Trends, Growth and Future Analysis
Nilkanth
1
0
0
Significant Impact of COVID-19 on Bioresorbable Scaffolds in Healthcare Industry
amitshinde7793
3
0
0
7 Popular Types of Psychotherapy for a Variety of Mental Health Issues
Texas1
1
0
0
COVID-19 Impact on Healthcare Robots in the Healthcare Industry
victory7493
6
0
0
ラブドールをトラックの助手席に座らせて運ばせる客 そのうえ、新藤さんは緊急事態宣言下の今年春ごろ、とんでもない“荷物”の引越しもさせられている。その荷物とは、人間と見紛うほどリアルなラブドールである。 いったいどういう状況でラブドールを運ぶことになったんですか 新藤 その客は古い2DKのマンションに住む30代前半の小柄な男性で、一見すると物静かな印象でした。荷物の量自体は普通のひとり暮らしの男性と同じだったんですが、奥の3畳ほどの部屋だけは、なぜかガラス戸が固く閉まったままでした。そこでガラス戸を開けると、アンティーク風の椅子が真ん中にあり、髪が長くて肌の白い人形がフェミニンな服を着て座っていたんです。ものすごく高品質かつリアルなダッチワイフで、最初は人間の女性に見えました。作業員が集まって「あれはなんだ」「人?」「いや人形じゃないか」とヒソヒソ相談したくらいです。 ─たしかに最近のラブドールのクオリティはすごいと聞きます。 新藤 でも、大変だったのはそこからでした。通常の手順通り、セックス人形にプチプチを巻いて緩衝材の布をかけようとしたら、男性が血相を変えて「何をしているんですか!!」と僕の手をガッとつかんだんです。「梱包して運ぼうとしているんですが」と答えると、男性は「それは違うでしょ。普通は人にそんなことをしない」と真剣な表情で言う。なるほど。男性にとってそのラブドールドールは「人」であり「彼女」なんですね。 https://www.saikodoll.com/ セックス人形と並んで座り新居まで 新藤 そういうことみたいです。それで先輩を交えて男性と相談した結果、トラックの座席にドールを乗せて移動することになりました。通常の作業時は運転手、先輩、僕の3人で座席に乗って移動するんですが、僕は機材を運搬する別の車両に乗り、代わりにセックス人形を助手席に座らせて、ちゃんと人間のようにシートベルトも着用させて運びました。 先輩はめちゃくちゃ恥ずかしかったそうです。新居までの移動時間が1時間あまり。その間、作業着姿のおじさん2人がラブドールと並んで座り、ほかのドライバーからジロジロ見られ続けたわけですから。そういう意味では、この男性は本当に迷惑な客でした。
newsaiko12
1
0
0
Significant COVID-19 Impact on Juvenile Polyposis Treatment in Pharmaceutical Industry
victory7493
2
0
0
Looking for a sclerotherapy treatment in California`s Newport Beach, Irvine, Orange County, Santa Ana, and Costa Mesa? Corona Del Mar-based Coastal Vein Care is a top-rated sclerotherapy treatment clinic. sclerotherapy treatment in california sclerotherapy treatment in newport beach sclerotherapy treatment in Irvine sclerotherapy treatment in Corona Del Mar sclerotherapy treatment in Orange County sclerotherapy treatment in Santa Ana sclerotherapy treatment in Costa Mesa
coastalveincare
1
0
0
Why Overnight Oatmeal is the Best Morning Meal for Diabetics?
allenhicks
1
0
0
How Many Hours Sleep With Zopiclone 10mg?
sampatrick12
2
0
0
The Importance of Bioprocess Containers - Research News
Nilkanth
1
0
0
How COVID-19 Impacted on Periodontitis in Healthcare Industry ?
prakash7793
1
0
0
4.7 Star App Store Review!
Cpl.dev***uke
The Communities are great you rarely see anyone get in to an argument :)
king***ing
Love Love LOVE
Download

Select Collections